Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination

Commentary notes taking novel vaccines successfully through phase 1 to 3 trials within a year has been outstanding achievement, but equally challenging over coming year will be persuading governments & populations to use vaccines effectively to create herd immunity to protect all

Source:

The Lancet